<DOC>
	<DOCNO>NCT01496677</DOCNO>
	<brief_summary>To compare pharmacokinetic ( PK ) profile TR-700 elderly subject versus young control subject</brief_summary>
	<brief_title>Pharmacokinetics , Safety , Tolerability TR-701 Free Acid ( FA ) Elderly Subjects</brief_title>
	<detailed_description>This open-label Phase 1 study single oral tablet TR-701 FA 200 mg compare TR-700 PK profile elderly subject ( age 65 year old , least 5 subject 75 year old old ) young control subject ( age 18 45 year ) .</detailed_description>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>Male female subject follow group : An elderly subject least 65 year age . At least 5 subject must least 75 year age OR A matchedcontrol subject 18 45 year age , inclusive BMI ≥18.0 kg/m2 ≤35.0 kg/m2 Elderly Group Medical history , physical examination , laboratory result consistent stable health ( determined Investigator ) Control Group Medically stable clinically significant abnormality Significant , uncontrolled , lifethreatening condition organ system condition disease ( eg , impaired cognitive status , respiratory insufficiency , advanced malnutrition ) Positive hepatitis B surface antigen , hepatitis C virus antibody , human immunodeficiency virus antibody test result Previous inclusion TR701 FA TR701 clinical study ECG find QTc interval &gt; 500 msec , clinically significant ECG abnormality Screening Female subject pregnant , lactate breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>volunteer</keyword>
</DOC>